Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorCAROLLE NGO BELL, Elisabeth
dc.contributor.authorCHAPON, Virginie
dc.contributor.authorBESSEDE, Emilie
dc.contributor.authorMERIGLIER, Etienne
dc.contributor.authorISSA, Nahema
dc.contributor.authorDOMBLIDES, Charlotte
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorBONNET, Fabrice
dc.contributor.authorVANDENHENDE, Marie-Anne
dc.date.accessioned2024-04-30T14:41:17Z
dc.date.available2024-04-30T14:41:17Z
dc.date.issued2024-02-01
dc.identifier.issn2666-9919en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/199550
dc.description.abstractEnBACKGROUND: Central catheter-related bloodstream infections (CRBIs) can lead to severe complications, including suppurative thrombophlebitis, endocarditis, and metastatic infections. While complications due to CRBIs caused by Staphylococcus aureus (SA) are well-known, there are limited data regarding CRBIs caused by other bacteria. METHODS: This 2-year retrospective single-center study of patients with CRBIs from a tertiary care hospital examined the hematogenous complications associated with CRBIs according to patient characteristics, central venous catheter (CVC) types, and causative bacteria. RESULTS: All in all, 254 patients with confirmed CRBIs were included; 285 bacteria types were isolated, mainly Enterobacteriaceae (n = 94), coagulase-negative Staphylococci (CNS, n = 82), SA (n = 45), and non-fermenting Gram-negative bacteria (NGB, n = 45). Among the patients, 35 developed at least one hematogenous complication (14%), including suppurative thrombophlebitis (n = 15), endocarditis (n = 7) and metastatic infections (n = 16). In multivariate analysis, hemodialysis, persistent bacteremia for at least 3 days, and CRBIs caused by SA were associated with increased risk for hematogenous complications, while previous curative anticoagulant treatment was associated with reduced risk. Diabetes, CVC maintenance, and hematogenous complications were associated with increased 3-month mortality. CONCLUSION: A thorough investigation of hematogenous complications should be envisioned in patients with persistent bacteremia, particularly those with SA infections and those on hemodialysis.
dc.language.isoENen_US
dc.subject.enBloodstream infection
dc.subject.enCatheter
dc.subject.enDeath
dc.subject.enEndocarditis
dc.subject.enHematogenous complication
dc.title.enCentral venous catheter-related bloodstream infections: Epidemiology and risk factors for hematogenous complications
dc.title.alternativeInfect Dis Nowen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.idnow.2024.104859en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed38309647en_US
bordeaux.journalInfectious Diseases Nowen_US
bordeaux.page104859en_US
bordeaux.volume54en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamGHIGS_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDInstitut de Recherche pour le Développementen_US
hal.identifierhal-04564580
hal.version1
hal.date.transferred2024-04-30T14:41:21Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Infectious%20Diseases%20Now&rft.date=2024-02-01&rft.volume=54&rft.issue=3&rft.spage=104859&rft.epage=104859&rft.eissn=2666-9919&rft.issn=2666-9919&rft.au=CAROLLE%20NGO%20BELL,%20Elisabeth&CHAPON,%20Virginie&BESSEDE,%20Emilie&MERIGLIER,%20Etienne&ISSA,%20Nahema&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record